Screening for early-stage Alzheimer’s disease is crucial to find the golden window for intervention before the onset of irreversible dementia. However, the current diagnostic tools are expensive, lead to radiation exposure, or are even invasive. Researchers have now identified a urine biomarker , formic acid, which showed sensitivity for the early screening of Alzheimer’s .
A study (n=574) involving healthy participants and those with different degrees of disease progression has found that urinary formic acid levels were significantly higher in the Alzheimer’s group compared to the control and also correlated with a cognitive decline . In addition, researchers reported that a combination of urinary formic acid levels and Alzheimer’s blood biomarkers could more accurately predict the stage of the disease . The benefits of this test include the convenience of detection ,…
